Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe
(NASDAQ: EOLS) Delayed: 6.59 -0.04 (0.6%)
Previous Close $6.63    52 Week High $ 
Open $6.56    52 Week Low $ 
Day High $6.68    P/E N/A 
Day Low $6.42    EPS $ 
Volume 375,332